Genesco reports $530 million Q2 sales and raises EPS outlook

Genesco reported Q2 revenue of $529.9M, down 3% YoY but in line with estimates. Adjusted EPS of -$0.83 beat estimates by 39.3%. Operating margin improved to 2.3% from -2.7% YoY. The company closed stores and invested in marketing, prioritizing margins over sales volume. Full-year EPS guidance of $2.20 at the midpoint misses estimates by 2.3%.

Genesco Inc (GCO) reported Q2 2027 earnings with adjusted EPS guidance raised to the high end of $2 to $2.40. Revenue fell 3% to $530M, but all divisions showed gains. Journeys saw 8 consecutive quarters of positive comps, while schuh's gross margin improved 300 bps. The company received $22M in tariff refunds. Q3 operating income is expected to be moderately below last year due to sales declines and increased marketing investments.

Genesco Inc. reported Q2 2027 earnings exceeding expectations, with gross margin improvements and expense management offsetting lower sales. Journeys saw positive comparable sales, Schuh faced sales pressure due to reduced discounting, and Johnston & Murphy grew through brand partnerships. The company raised full-year EPS guidance to $2.00-$2.40 and plans structural cost savings. Inventory increased 8% year-over-year, and $22 million in tariff refunds were received. Management expects continued

Genesco (GCO) stock rose 5.4% after reporting Q2 net sales of $529.9M, a 1% drop in total comparable sales, and raised full-year adjusted EPS guidance to the high end of its $2.00-$2.40 range. The company reported a GAAP EPS of $0.32 and an adjusted loss of $0.83, beating expectations. Shares later cooled to $34.29, up 2.2%.

Genesco (GCO) reported Q2 earnings, highlighting Journeys' 8th consecutive quarter of positive comparable sales, driven by lifestyle athletic products and its 4.0 store format. Schuh focused on margin recovery, improving gross margin by 300 basis points. Johnston & Murphy saw growth in apparel and casual footwear. Genesco raised its full-year EPS guidance to the high end of $2.00-$2.40 and expects flat comparable sales. The company received $22M in tariff refunds, excluded from adjusted results.

Genesco shares rose 8% in pre-market trading after Q2 2027 earnings beat expectations, with a net loss of $0.83 per share and net sales of $530M. Sales were driven by Johnston & Murphy's 5% increase, offsetting declines elsewhere. The company raised its full-year adjusted EPS outlook to the high end of $2.00-$2.40, while lowering sales expectations to -2% from flat.